详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA, [2]Institut Sainte Catherine, Avignon, France, [3]BeiGene, San Mateo, CA, USA, [4]Oslo University Hospital, Oslo, [5]KG Jebsen Centre for B cell malignancies, Oslo, Norway, [6]Mayo Clinic, Rochester, MN, USA, [7]Princess Margaret Cancer Centre, Toronto, Canada, [8]Singapore General Hospital, Singapore, Singapore, [9]Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea, [10]Instituto do Cancer, Hospital M~ae de Deus, Porto Alegre, Brazil, [11]West China Hospital of Sichuan University, Chengdu, China, [12]Infectious Disease Research Institute, Seattle, WA, [13]Fred Hutchinson Cancer Research Center, Seattle, WA, [14]University of Washington, Seattle, WA, USA, [15]Christie Hospital & University of Manchester, Manchester, UK [16]Sir YK Pao Centre for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.

出处：

DOI：

ISSN：

关键词： siltuximab multicentric Castleman disease

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区

医学

小类 | 2 区血液学

最新[2023]版：

大类 | 2 区

医学

小类 | 2 区血液学

第一作者：

第一作者机构： [1]Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA,

推荐引用方式(GB/T 7714)：

APA：

MLA：

Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab.

文献详情

相关文献